Characterization of methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci and extended-spectrum beta-lactamase-producing Escherichia coli in intensive care units in Canada: Results of the Canadian National Intensive Care Unit (CAN-ICU) study (2005-2006)

Canadian Journal of Infectious Diseases and Medical Microbiology

Volumn 19, Issue 3, 2008, Pages 243-249

  Zhanel, George G ^a,b   DeCorby, Mel ^a,b   Nichol, Kim A ^b   Baudry, Patricia J ^a,b   Karlowsky, James A ^a,b   Lagace Wiens, Philippe R S ^a,b   McCracken, Melissa ^c   Mulvey, Michael R ^c   Hoban, Daryl J ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b HEALTH SCIENCES CENTRE   (Canada)

^c PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

CAN ICU; ESBL E coli; Intensive care; MRSA; Resistance; VRE

Indexed keywords

BETA LACTAMASE; CEFTRIAXONE; CEPHALOSPORIN; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; DALBAVANCIN; DAPTOMYCIN; DOXYCYCLINE; ERTAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; LEVOFLOXACIN; LINEZOLID; MEROPENEM; MOXIFLOXACIN; PANTON VALENTINE LEUKOCIDIN; PENICILLIN BINDING PROTEIN 2A; PIPERACILLIN PLUS TAZOBACTAM; TIGECYCLINE; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CANADA; CHILD; CLINICAL ARTICLE; DISK DIFFUSION; ESCHERICHIA COLI; FEMALE; GENE; GENOTYPE PHENOTYPE CORRELATION; HEALTH CARE; HOSPITAL INFECTION; HUMAN; INFANT; INTENSIVE CARE UNIT; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; SEQUENCE ANALYSIS; VANA GENE; VANB GENE; VANCOMYCIN RESISTANT ENTEROCOCCUS;

EID: 49149103382     PISSN: 17129532     EISSN: None     Source Type: Journal    
DOI: 10.1155/2008/714846     Document Type: Article

References (25)

1. Intensive Care Antimicrobial Resistance Epidemiology (ICARE) Surveillance Report, data summary from January 1996 through December 1997: A report from the National Nosocomial Infections Surveillance (NNIS) System. Am J Infect Control 1999;27:279-84.
2. Esposito S, Leone S. Antimicrobial treatment for intensive care unit (ICU) infections including the role of the infectious diseases specialist. Int J Antimicrob Agents 2007;29:494-500.
3. Klevens RM, Edwards JR, Richards CL Jr, et al. Estimating health-care associated infections and deaths in US hospitals, 2002. Public Health Rep 2007;122:160-6.
4. Rhomberg PR, Fritsche TR, Sader HS, Jones RN. Antimicrobial susceptibility pattern comparisons among intensive care unit and general ward Gram-negative isolates from the Meropenem Yearly Susceptibility Test Information Collection Program (USA). Diagn Microbiol Infect Dis 2006;56:57-62.
5. Deshpande LM, Fritsche TR, Moet GJ, Biedenbach GJ, Jones RN. Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: A report from the SENTRY antimicrobial surveillance program. Diagn Microbiol Infect Dis 2007;58:163-70.
6. Levin PD, Fowler RA, Guest C, Sibbald WJ, Kiss A, Simor AE. Risk factors associated with resistance to ciprofloxacin in clinical bacterial isolates from intensive care unit patients. Infect Control Hosp Epidemiol 2007;28:331-6.
7. Lockhart SR, Abramson MA, Beekman SE, et al. Antimicrobial resistance among Gram-negative bacilli as causes of infections in intensive care unit patients in the United States between 1993 and 2004. J Clin Microbiol 2007;45:3352-9.
8. Moland ES, Hanson ND, Black JA, Hossain A, Song W, Thomson KS. Prevalence of newer beta-lactamases in gram-negative clinical isolates collected in the US from 2001 to 2002. J Clin Microbiol 2006;44:3318-324.
9. Mulvey MR, Bryce E, Boyd D, et al; Canadian Hospital Epidemiology Committee, Canadian Nosocomial Infection Surveillance Program, Health Canada. Ampler class A extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella spp. in Canadian hospitals. Antimicrob Agents Chemother 2004;48:1204-14.
10. Mulvey MR, Chiu L, Ismail J, et al; Canadian Committee for the Standardization of Molecular Methods. Development of a Canadian standardized protocol for subtyping methicillin-resistant Staphylococcus aureus using pulsed-field gel electrophoresis. J Clin Microbiol 2001;9:3481-5.
11. Mulvey MR, MacDougall L, Cholin B, et al. Community-associated methicillin-resistant Staphylococcus aureus, Canada. Emerg Infect Dis 2005;11:844-50.
12. Pitout JD, Nordmann DP, Laupland KB, Poirel L. Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community. J Antimicrob Chemother 2005;56:52-9.
13. Pitout JD, Church DL, Gregson DB, et al. Molecular epidemiology of CTX-M-producing Escherichia coli in the Calgary Health Region: Emergence of CTX-M-15 producing isolates. Antimicrob Agents Chemother 2007;51:1281-6.
14. Zhanel GG, Laing NM, Nichol KA, et al; NAVRESS Group. Antibiotic activity against urinary tract infection (UTI) isolates of vancomycin-resistant enterococci (VRE): Results from the 2002 North America Vancomycin Resistant Enterococci Susceptibility Study (NAVRESS). J Antimicrob Chemother 2004;52:382-8.
15. Rubinstein E, Zhanel GG. Anti-infectives research and development problems challenges and solutions: The clinical practitioner perspective. Lancet Infect Dis 2007;7:69-70.
16. Zhanel GG, Decorby M, Laing N, et al; The Canadian Antimicrobial Resistance Alliance (CARA). Antimicrobial-resistant pathogens in intensive care units in Canada: Results of the Canadian National Intensive Care Unit (CAN-ICU) Study, 2005-2006. Antimicrob Agents Chemother 2008;52:1430-7.
17. Oliveira DC, de Lencastre H. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2002;46:2155-61.
18. Christianson S, Golding GR, Campbell J, Mulvey MR; Canadian Nosocomial Infection Surveillance Program. Comparative genomics of Canadian epidemic lineages of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2007;45:1904-11.
19. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: Criteria for bacterial strain typing. J Clin Microbiol 1995;33:2233-9.
20. Boyd DA, Kibsey P, Roscoe D, Mulvey MR. Enterococcus faecium N03-0072 carries a new VanD-type vancomycin resistance determinant: Characterization of the VanD5 operon. J Antimicrob Chemother 2004;54:680-3.
21. Ylipalosaari P, Ala-Kokko TI, Laurila J, Ohtonen P, Syrjälä H. Epidemiology of intensive care unit (ICU)-acquired infections in a 14-month prospective cohort study in a single mixed Scandinavian university hospital ICU. Acta Anaesthesiol Scand 2006;50:1192-7.
22. Chambers HF. Community-associated MRSA - resistance and virulence converge. N Engl J Med 2005;352:1485-7.
23. Gilbert M, MacDonald J, Gregson D, et al. Outbreak in Alberta of community-acquired (USA300) methicillin-resistant Staphylococcus aureus in people with a history of drug use, homelessness and incarceration. Can Med Assoc J 2006;175:149-54.
24. Farr B. What to think if the results of the National Institutes of Health randomized trial of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus control measures are negative (and other advice to young epidemiologists): A review and an au revoir. Infect Control Hosp Epidemiol 2006;27:1096-106.
25. Shadel BN, Puzniak LA, Gillespie KN, Lawrence SJ, Kollef M, Mundy LM. Surveillance for vancomycin-resistant enterococci: Type, rates costs and implications. Infect Cont Hosp Epid 2006;27:1068-75.